Clinical Trial Update: Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial comparing cortisone and drug-eluting stents against bare metal stents for restenosis in coronary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Bare-metal stent (bare-metal stent)
• Cortisone (cortisone)
• Drug-eluting stent (drug-eluting stent)

Snippet

Sponsor: Universita di Verona | Conditions: Coronary Artery Disease, Ischemic Heart Disease | Phase 2, Phase 3 | Status: COMPLETED